Join the Naloxone group to help and get support from people like you.
Naloxone News
Naloxone Implant Might Prevent Opioid Overdose
THURSDAY, Oct. 24, 2024 – Naloxone can save a person’s life by reversing a potentially fatal opioid overdose, and is now available as an over-the-counter medication. Unfortunately, there’s a very sig...
Naloxone Implant Might Prevent Opioid Overdose
THURSDAY, Oct. 24, 2024 – Naloxone can save a person’s life by reversing a potentially fatal opioid overdose, and is now available as an over-the-counter medication. Unfortunately, there’s a very sig...
Fatal Opioid-Meth Overdoses Have Fallen in U.S. by More Than a Third
TUESDAY, Oct. 22, 2024 – Expanded access to addiction treatment and the overdose-reversal med naloxone likely prompted a 37% reduction in OD deaths linked to opioids taken with meth or other...
Methadone Tied to Lower Risk for Discontinuation Versus Buprenorphine/Naloxone
FRIDAY, Oct. 18, 2024 – Receipt of methadone for opioid use disorder is associated with a lower risk for treatment discontinuation compared with buprenorphine/naloxone, according to a study...
Rate of Layperson-Administered Naloxone Increased From 2020 to 2022
WEDNESDAY, Oct. 16, 2024 – The rate of layperson-administered naloxone (LAN) increased from 2020 to 2022, according to a study published online Oct. 14 in JAMA Network Open. Christopher B. Gage, ...
More Bystanders Are Using Naloxone to Save Folks From Overdose
MONDAY, Oct. 14, 2024 – More bystanders are stepping in to administer naloxone to people who’ve overdosed on opioids, a new study shows. Nearly 25,000 OD patients received naloxone from an untrained ...
2017 to 2022 Saw Increase in Naloxone Prescribing Among Adolescents
THURSDAY, Sept. 12, 2024 – From 2017 to 2022, there was an increase in naloxone prescribing among adolescents, with pediatricians accounting for an increasing proportion of prescriptions dispensed,...
FDA Approves RiVive (naloxone hydrochloride) Over-the-Counter Nasal Spray for the Emergency Treatment of Opioid Overdose
Pittsburgh, Pennsylvania--(Newsfile Corp. - July 28, 2023) - Harm Reduction Therapeutics (HRT), Inc., a nonprofit pharmaceutical company, announced today that FDA has approved OTC RiVive™ (naloxone H...
FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ Narcan Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
GAITHERSBURG, Md., March 29, 2023 (GLOBE NEWSWIRE) – Today, Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved Narcan® Naloxone HCl Nasal ...
FDA Approves Zimhi (naloxone hydrochloride) Injection for the Treatment of Opioid Overdose
SAN DIEGO, Oct. 18, 2021 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced that the U.S. Food and Drug Administration (FDA) has approved Adamis’ Zimhi™ (naloxone HC...
FDA Approves Kloxxado (naloxone hydrochloride) Nasal Spray for Emergency Treatment of Opioid Overdose
LONDON, April 30, 2021 /PRNewswire/ – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces the approval of Kloxxado (naloxone hydrochloride) nasal spray 8mg, by the...
FDA Medwatch Alert: Opioid Pain Relievers or Medicines to Treat Opioid Use Disorder - FDA Recommends Health Care Professionals Discuss Naloxone with All Patients when Prescribing
ISSUE: FDA is requiring drug manufacturers for all opioid pain relievers and medicines to treat opioid use disorder (OUD) to add new recommendations about naloxone to the prescribing information....
FDA Medwatch Alert: Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL in the Carpuject™ Single-use Cartridge Syringe System by Hospira: Recall - Due to the Potential Presence of Particulate Matter
ISSUE: Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe...
Narcan (naloxone HCl) Nasal Spray 2mg Approved by U.S. Food and Drug Administration
January 25, 2017 – Dublin, Ireland – Today, the U.S. Food and Drug Administration (FDA) approved Narcan Nasal Spray as a 2mg formulation for the emergency treatment of known or suspected opioid ove...
FDA Approves Narcan (naloxone) Nasal Spray to Treat Opioid Overdose
November 18, 2015 – Today the U.S. Food and Drug Administration approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can...